Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-24 Dere Willard H Director Grant or award +4,980 23,390
2022-05-24 ANDERSON ELIZABETH M Director Grant or award +4,980 18,890
2022-05-24 Alles Mark J Director Grant or award +4,980 7,280
2022-05-16 Burkhart Erin GVP, Chief Accounting Officer Grant or award +11,130 11,130
2022-05-16 Burkhart Erin GVP, Chief Accounting Officer Grant or award · Stock Option (Right to buy Common Stock) +17,490 17,490
2022-05-06 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +20,000 $37.46 $749K 355,324
2022-05-06 BIENAIME JEAN JACQUES Chief Executive Officer Sale −20,000 $81.00 $1.6M 335,324
2022-05-06 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −20,000 0
2022-05-05 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +10,000 $37.46 $375K 345,324
2022-05-05 BIENAIME JEAN JACQUES Chief Executive Officer Sale −10,000 $84.14 $841K 335,324
2022-05-05 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −10,000 20,000
2022-05-04 Guyer Charles Greg EVP, Chief Technical Officer Shares withheld for taxes −3,926 $84.65 $332K 48,373
2022-05-04 Mueller Brian EVP, Chief Financial Officer Exercise or conversion +2,038 $37.46 $76K 40,677
2022-05-04 Mueller Brian EVP, Chief Financial Officer Sale −2,038 $84.50 $172K 38,639
2022-05-04 Mueller Brian EVP, Chief Financial Officer Exercise or conversion +9,762 $37.46 $366K 48,401
2022-05-04 Mueller Brian EVP, Chief Financial Officer Sale −9,762 $84.50 $825K 38,639
2022-05-04 Mueller Brian EVP, Chief Financial Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −2,038 0
2022-05-04 Mueller Brian EVP, Chief Financial Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −9,762 0
2022-05-02 MEIER RICHARD A Director Exercise or conversion +8,500 $37.46 $318K 107,892
2022-05-02 MEIER RICHARD A Director Sale −3,860 $82.09 $317K 104,032

Page 22 of 23 · 450 trades